Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Carola Metzig"'
Publikováno v:
Journal of Ophthalmology, Vol 2018 (2018)
Purpose. To report the impact of baseline central retinal thickness (CRT) on outcomes in patients with diabetic macular edema (DME) in VIVID-DME and VISTA-DME. Methods. Post hoc analyses of two randomized controlled trials in which 862 DME patients w
Externí odkaz:
https://doaj.org/article/49f10e630ebc4907adbab54e4c2a2b2a
Autor:
Desmond Thompson, Dilsher S. Dhoot, Rishi P Singh, Namrata Saroj, Robert Vitti, Alyson J. Berliner, Keith Baker, Carola Metzig
Publikováno v:
Ophthalmology. 125:51-56
Purpose To evaluate whether select baseline systemic and ocular factors influence ≥2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) score at week 100 in VISTA and VIVID. Design Post hoc analysis of 2 similarly designed phase 3 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92b010bf16947fe1d2175e3c34020289
https://doi.org/10.1016/j.ophtha.2017.06.029
https://doi.org/10.1016/j.ophtha.2017.06.029
Autor:
Frank G. Holz, Carola Metzig, Giovanni Staurenghi, Nicolas Feltgen, Jennifer J. Arnold, Chengxing Lu, Todd A. Katz
Publikováno v:
The British Journal of Ophthalmology
Background/aimsTo evaluate intravitreal aflibercept versus laser in subgroups of patients with baseline Diabetic Retinopathy Severity Scale (DRSS) scores ≤43, 47, and ≥53 in VIVID-DME and VISTA-DME.MethodsPatients with diabetic macular oedema wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075b06c512eaf1dc106bf9aa685c8a56
https://doi.org/10.1136/bjophthalmol-2017-310664
https://doi.org/10.1136/bjophthalmol-2017-310664
Autor:
Alyson J. Berliner, Charles C. Wykoff, Michael Larsen, Fabiana Q. Silva, Carola Metzig, Oliver Zeitz, Quan Dong Nguyen, Andrea Gibson, Desmond Thompson, Hiroko Terasaki, Namrata Saroj, David M. Brown, Rishi P Singh, Sangeeta Kayshap, Robert Vitti
Publikováno v:
Ophthalmology Retina. 1:382-388
Purpose To examine the relationship between glycemic control at baseline and response to anti–vascular endothelial growth factor treatment for diabetic macular edema (DME). Design Post hoc analysis of 2 similarly designed phase III trials, VISTA an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f7bfe19d782e6b2c4ded52926d91822
https://doi.org/10.1016/j.oret.2017.02.003
https://doi.org/10.1016/j.oret.2017.02.003
Autor:
Michael R. Lassen, Scott D. Berkowitz, Bastian Becker, Jeffrey I. Weitz, Rupert Bauersachs, Gary E. Raskob, Maria C. S. Freitas, Carola Metzig
Publikováno v:
JAMA
Importance The efficacy of factor XIa inhibition for thromboprophylaxis is unknown. Osocimab is a long-acting, fully human monoclonal antibody that inhibits factor XIa. Objective To compare different doses of osocimab with enoxaparin and apixaban for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3630551d6988377ac3ff6cb5bc2b0490
https://pubmed.ncbi.nlm.nih.gov/31935013
https://pubmed.ncbi.nlm.nih.gov/31935013
Autor:
Alyson J. Berliner, Hanna R. Coleman, Charles C. Wykoff, Keith Baker, Desmond Thompson, Dilsher S. Dhoot, Chirag P. Shah, Namrata Saroj, Carola Metzig, Weiming Du, Robert Vitti
Publikováno v:
Ophthalmology. 126(8)
Purpose To evaluate changes in retinal perfusion status with intravitreal aflibercept injection (IAI) and laser treatment in the phase 3 VISTA study of patients with diabetic macular edema (DME). Design Post hoc analysis of a double-masked, randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5eb5587164c8e9f62a9aac988b0807
https://pubmed.ncbi.nlm.nih.gov/30946887
https://pubmed.ncbi.nlm.nih.gov/30946887
Autor:
Olaf Sowade, Thomas Schmelter, Alyson J. Berliner, Masato Kobayashi, Masahito Ohji, Fumio Shiraga, Kunihiko Shiraki, Hiroko Terasaki, Carola Metzig, Robert Vitti, Oliver Zeitz
Publikováno v:
Retina (Philadelphia, Pa.)
Supplemental Digital Content is Available in the Text. Intravitreal aflibercept injection was superior to laser for visual and anatomical outcomes in Japanese patients with DME. In addition, intravitreal aflibercept injection resulted in efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65050f52aefbcd994d26096efbe71146
https://pubmed.ncbi.nlm.nih.gov/29470308
https://pubmed.ncbi.nlm.nih.gov/29470308
Autor:
Glenn J. Jaffe, Frank G. Holz, Neil Stahl, Jean-François Korobelnik, Ursula Schmidt-Erfurth, Jeffrey S. Heier, Dennis M. Marcus, David S. Boyer, Jason S. Slakter, Peter K. Kaiser, Robert Vitti, Quan Dong Nguyen, David M. Brown, Christian Simader, Yuhwen Soo, Alyson J. Berliner, Hiroko Terasaki, Oliver Zeitz, Thomas Schmelter, Edoardo Midena, George D. Yancopoulos, Diana V. Do, Carola Metzig
Publikováno v:
Ophthalmology. 122:2044-2052
Purpose To compare efficacy and safety of 2 dosing regimens of intravitreal aflibercept injection (IAI) with macular laser photocoagulation for diabetic macular edema (DME). Design Two similarly designed, randomized, phase 3 trials, VISTA DME and VIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87a970c9927dd807bc7ab37b78a269cc
https://doi.org/10.1016/j.ophtha.2015.06.017
https://doi.org/10.1016/j.ophtha.2015.06.017
Autor:
Jean-François Korobelnik, Michael Larsen, Giovanni Staurenghi, David M. Brown, Oliver Zeitz, Todd A. Katz, David S. Boyer, Paul Mitchell, Alyson J. Berliner, Robert Vitti, Diana V. Do, Carola Metzig, Chengxing Lu, Frank G. Holz, Ian L. McAllister
Publikováno v:
Ophthalmology Retina
Ophthalmology Retina, Elsevier, 2018, 2 (10), pp.988-996. ⟨10.1016/j.oret.2018.02.011⟩
Ophthalmology Retina, Elsevier, 2018, 2 (10), pp.988-996. ⟨10.1016/j.oret.2018.02.011⟩
International audience; PURPOSE: To evaluate the impact of intravitreal aflibercept (EYLEA, Regeneron Pharmaceuticals, Tarrytown, NY) versus laser on progression of diabetic retinopathy (DR) severity in Intravitreal Aflibercept Injection in Vision Im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dcc4fbf3481c2601a6d47c94e9a9893
https://hal.archives-ouvertes.fr/hal-03164912/file/BPH_OR_2018_Mitchell.pdf
https://hal.archives-ouvertes.fr/hal-03164912/file/BPH_OR_2018_Mitchell.pdf
Publikováno v:
Journal of Ophthalmology
Journal of Ophthalmology, Vol 2018 (2018)
Journal of Ophthalmology, Vol 2018 (2018)
Purpose. To report the impact of baseline central retinal thickness (CRT) on outcomes in patients with diabetic macular edema (DME) in VIVID-DME and VISTA-DME. Methods. Post hoc analyses of two randomized controlled trials in which 862 DME patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552d17f263adc2e954c2516225c6f149
https://pubmed.ncbi.nlm.nih.gov/29785301
https://pubmed.ncbi.nlm.nih.gov/29785301